TUSC8: A Tumor Suppressor Candidate for Targeted Therapeutic Interventions

Target Name: TUSC8

NCBI ID: G400128

TUSC8

Other Name(s): tumor suppressor candidate 8 | LINC01071 | XLOC_010588 | Tumor suppressor candidate 8

TUSC8: A Tumor Suppressor Candidate for Targeted Therapeutic Interventions

Abstract:

Tumor suppressor candidate (TSC) genes are potential drug targets for cancer therapy. TUSC8, a tumor suppressor gene located in chromosome 8, has been identified as a promising TSG candidate. This article reviews the current research on TUSC8, including its expression, function, and potential as a drug target or biomarker.

Introduction:

Cancer is a leading cause of human mortality, with over 20% of all deaths worldwide due to cancer. The development of new cancer therapies is crucial for improving treatment outcomes. One approach to combatting cancer is to target genes that are associated with tumor suppressancy, such as TSCs. TSCs are genomic regions that have the potential to suppress tumor growth and have been implicated in cancer development. Tumor suppressor candidate (TSC) genes are one of the most promising candidates for cancer therapies. TUSC8, a gene located in chromosome 8 , has been identified as a promising TSG candidate.

Structure and Expression:

TSCs are genomic regions that have the potential to suppress tumor growth. These regions often have unique expression patterns compared to other tissues and are associated with tumor suppressor genes. The gene TUSC8, located in chromosome 8, is a TSG candidate that has been shown to have unique expression patterns in various tissues.

TUSC8 is a highly conserved gene that is expressed in various tissues, including brain, heart, and muscle. It has been shown to have distinct expression patterns in these tissues, which may indicate its unique functions in each of these organs. to have high expression in the brain, suggesting that it may be involved in brain development and function.

Function and Potential as a Drug Target:

TUSC8 has been shown to have various functions that make it a promising TSG candidate. TUSC8 has been shown to be involved in cell adhesion, migration, and invasion. It has also been shown to play a role in the development and progression of various diseases, including cancer.

One of the most promising aspects of TUSC8 is its potential as a drug target. TUSC8 has been shown to have unique expression patterns in various tissues, which may indicate its unique functions in each of these organs. This suggests that TUSC8 may be a useful target for the development of new cancer therapies.

TUSC8 has also been shown to have a role in the regulation of cellular processes that are important for cancer development. For example, TUSC8 has been shown to play a role in the regulation of the angiogenic switch, which is the process by which cells become blood vessels Endothelial cells, which are important for the growth and spread of cancer.

Potential as a Biomarker:

TUSC8 has also been shown to have potential as a biomarker for cancer. The expression of TUSC8 has been shown to be associated with the development and progression of various cancers, including breast, ovarian, and colorectal cancers. This suggests that TUSC8 may be a useful biomarker for the diagnosis and treatment of cancer.

Conclusion:

TUSC8 is a promising TSG candidate that has unique expression patterns in various tissues and has been shown to have various functions that make it a promising target for cancer therapies. Further research is needed to fully understand the potential of TUSC8 as a drug target and biomarker for cancer.

Protein Name: Tumor Suppressor Candidate 8

The "TUSC8 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TUSC8 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets